Brain Shuttle Neprilysin reduces central Amyloid-β levels

PloS One
Christopher R CamposEduard Urich

Abstract

Reducing Amyloid β (Aβ) in the brain is of fundamental importance for advancing the therapeutics for Alzheimer`s disease. The endogenous metallopeptidase neprilysin (NEP) has been identified as one of the key Aβ-degrading enzymes. Delivery of NEP to the brain by utilizing the Brain Shuttle (BS) transport system offers a promising approach for clearing central Aβ. We fused the extracellular catalytic domain of NEP to an active or inactive BS module. The two BS-NEP constructs were used to investigate the pharmacokinetic/pharmacodynamics relationships in the blood and the cerebrospinal fluid (CSF) in dose-response and multiple dosing. As previously shown, NEP was highly effective at degrading Aβ in blood but not in the CSF compartment after systemic administration. In contrast, the NEP with an active BS module led to a significant CSF exposure of BS-NEP, followed by substantial Aβ reduction in CSF and brain parenchyma. Our data show that a BS module against the transferrin receptor facilitates the transport of an Aβ degrading enzyme across the blood-brain barriers to efficiently reduce Aβ levels in both CSF and brain.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P M FridenR M Starzyk
Oct 18, 2005·FEBS Letters·Roberta RussoAlessandra Piccini
Dec 31, 2005·The Journal of Pharmacology and Experimental Therapeutics·Li-Bo ZouToshitaka Nabeshima
Apr 9, 2008·Current Alzheimer Research·Louis B Hersh, David W Rodgers
Apr 12, 2008·The American Journal of Pathology·Salim S El-AmouriMark S Kindy
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·M Paul Murphy, Harry LeVine
Feb 10, 2011·Nature Reviews. Neurology·Christiane ReitzRichard Mayeux
Oct 18, 2011·Journal of Neuropathology and Experimental Neurology·James Scott MinersSeth Love
Sep 29, 2015·Scientific Reports·Eduard UrichPer-Ola Freskgård
Jun 23, 2018·Theranostics·Kasper Bendix JohnsenThomas Lars Andresen
Jan 6, 2019·Nature Reviews. Neurology·Francesco PanzaBruno P Imbimbo
Jan 13, 2019·Annals of Neurology·Francesco PanzaBruno P Imbimbo

❮ Previous
Next ❯

Methods Mentioned

BETA
size exclusion chromatography
FACS
FCS
ELISA
flow cytometry

Software Mentioned

XLFit
Envision Reader

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.